25. Lucchi L, Moresco RM, Govoni S, Trabucchi M: Effect of chronic
ethanol treatment on dopamine receptor subtypes in rat striatum. Brain
RCS449:347-351, 1988
26. Pellegrino SM, Druse MJ: The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems. Alcohol Clin
Exp Res 16:275-280, 1992
27. Hamdi A, Prasad C: Bidirectional changes in striatal D, dopamine
receptor density during chronic ethanol intake. Life Sci 52:251-257, 1993
28. Angulo JA: Involvement of dopamine D, and D, receptors in the
regulation of proenkephalin mRNA abundance in the striatum and ac-curnbens of the rat brain. J Neurochem 58:1104-1109, 1992
29. Hooks MS, Kalivas PW: Involvement of dopamine and excitatory
amino acid transmission in novelty-induced motor activity. J Pharmacol
Exp "her 269:976-988, 1994
30. Hunter GA, Beaman CM, Dunn LL, Reid LD: Selected opioids,
ethanol and intake of ethanol. Alcohol 1:43-46, 1984
31. Hubbell CL, Czirr SA, Reid LD: Persistence and specificity of small
doses of morphine on intake of alcoholic beverages. Alcohol 4:149-156,
1987
32. Koob G F Neural Mechanisms of Drug Reinforcement. A n n NY
Acad Sci 654:171-191, 1992
33. Marfaing-Jallat PD, Miceli D, LeMagnen J: Decrease in ethanol
consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav 185355-5395, 1983
34. Reid LD, Hunter GA: Morphine and naloxone modulate intake of
ethanol. Alcohol 1:33-37, 1984
35. Sandi C, Borell J, Guzaz C: Naloxone decreases ethanol consumption within a free choice paradigm in rats. Pharmacol Biochem Behav
29139-43, 1988
36. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone
in the treatment of alcohol dependence. Arch Gen Psychiatry 49876-880,
1992
37. Gianoulakis C, de Waele JP: Genetics of alcoholism: Role of the
endogenous opioid system. Metab Brain Dis 9:105-131, 1994
38. Mason BJ, Ritvo ED, Morgan RO, Salvato FR, Goldberg G, Welch
B, Manteroatienza E: A double-blind, placebo-controlled pilot study to
evaluate the efficacy and safety of oral nalmefene HCI for alcohol dependence. Alcohol Clin Exp Res 18:1162-1167, 1994
39. O'Brien CP: Treatment of alcoholism as a chronic disorder. Alcohol 11:433-437, 1994
40. Quirion R, Rowe WB, Lapchak PA, Araujo, Beaudet A: Distribution of neurotensin receptors in mammalian brain. A n n NY Acad Sci
668~109-119,1992
41. Merchant KM, Gibb JW, Hanson GR: Role of dopamine D-1 and
D-2 receptors in the regulation of neurotensin systems of the neostriatum
and the nucleus accumbens. Eur J Pharmacol 160:409-412, 1989
42. Merchant KM, Miller MA, Ashleigh EA, Dorsa DM: Haloperidol
rapidly increases the number of neurotensin mRNA-expressing neurons in
neostriatum of the rat brain. Brain Res 540:311-314, 1991
43. Merchant KM, Dobner PR, Dorsa DM: Differential effects of
haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci 12:652-663, 1992
44. Castel MN, Morino P, Hokfelt T: Modulation of the neurotensin
striato-nigral pathway by D1 receptors. NeuroReport 5981-284, 1993
45. Diaz J, Levesque D, Griffon N, Lammers CH, Martres MP,
Sokoloff P, Schwartz JC: Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384-1387, 1994
46. Alexander MJ, Miller MA, Dorsa DM, Bullock BP, Mellon RH,
Dobner R, Leeman SE: Distribution of neurotensidneuromedin N
mRNA in rat forebrain. Unexpected abundance in hippocampus and
subiculum. Proc Natl Acad Sci USA 86:5202-5206, 1989
47. Morin AJ, Tajani M, Jones BE, Beaudet A: Spatial relationship
between neurotensinergic axons and cholinergic neurons in the rat basal
forebrain: A light microscopic study with three-dimensional reconstruction. J Chem Neuroanat 10147-156, 1996
